Who Paid My Doc
NanoKnife
Device Oncology Surgery
PDI H78720300301US0
General payments
$14,780,585
Research payments
$552,167
Through program year 2025, $14,780,585 in general payments and $552,167 in research payments were reported against NanoKnife (Oncology Surgery).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $4,578,167 | 109 |
| 2025 | Research | $60,000 | 1 |
| 2024 | General | $4,141,752 | 90 |
| 2024 | Research | $60,000 | 1 |
| 2023 | General | $2,923,333 | 74 |
| 2023 | Research | $300,000 | 5 |
| 2022 | General | $1,981,333 | 48 |
| 2022 | Research | $72,167 | 2 |
| 2021 | General | $1,156,000 | 32 |
| 2021 | Research | $60,000 | 1 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 33 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
353 general · 10 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.